NO20021866D0 - Ciclesonid-inneholdende vandig farmasöytisk blanding - Google Patents

Ciclesonid-inneholdende vandig farmasöytisk blanding

Info

Publication number
NO20021866D0
NO20021866D0 NO20021866A NO20021866A NO20021866D0 NO 20021866 D0 NO20021866 D0 NO 20021866D0 NO 20021866 A NO20021866 A NO 20021866A NO 20021866 A NO20021866 A NO 20021866A NO 20021866 D0 NO20021866 D0 NO 20021866D0
Authority
NO
Norway
Prior art keywords
ciclesonide
pharmaceutical composition
containing aqueous
aqueous pharmaceutical
composition
Prior art date
Application number
NO20021866A
Other languages
English (en)
Other versions
NO20021866L (no
NO327379B1 (no
Inventor
Atsuhiro Nagano
Yoshihisa Nishibe
Kazuya Takanashi
Original Assignee
Nycomed Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=17856339&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20021866(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nycomed Gmbh filed Critical Nycomed Gmbh
Publication of NO20021866L publication Critical patent/NO20021866L/no
Publication of NO20021866D0 publication Critical patent/NO20021866D0/no
Publication of NO327379B1 publication Critical patent/NO327379B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/44—Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/46—Drugs for disorders of the endocrine system of the suprarenal hormones for decreasing, blocking or antagonising the activity of glucocorticosteroids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20021866A 1999-10-20 2002-04-19 Ciclesonidinneholdende vandig farmasøytisk blanding NO327379B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP29818699 1999-10-20
PCT/JP2000/007351 WO2001028563A1 (en) 1999-10-20 2000-10-20 Ciclesonide-containing aqueous pharmaceutical composition

Publications (3)

Publication Number Publication Date
NO20021866L NO20021866L (no) 2002-04-19
NO20021866D0 true NO20021866D0 (no) 2002-04-19
NO327379B1 NO327379B1 (no) 2009-06-22

Family

ID=17856339

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20021866A NO327379B1 (no) 1999-10-20 2002-04-19 Ciclesonidinneholdende vandig farmasøytisk blanding

Country Status (36)

Country Link
US (2) US8383611B1 (no)
EP (1) EP1227817B1 (no)
JP (1) JP4856338B2 (no)
KR (1) KR100705372B1 (no)
CN (1) CN1198623C (no)
AR (1) AR026073A1 (no)
AT (1) ATE270107T1 (no)
AU (1) AU776587B2 (no)
BG (1) BG65799B1 (no)
BR (1) BRPI0014880B8 (no)
CA (1) CA2388325C (no)
CO (1) CO5251406A1 (no)
CZ (1) CZ297780B6 (no)
DE (1) DE60011924T2 (no)
DK (1) DK1227817T3 (no)
EA (1) EA005201B1 (no)
ES (1) ES2223595T3 (no)
HK (1) HK1051003A1 (no)
HR (1) HRP20020345B1 (no)
HU (1) HU228894B1 (no)
IL (2) IL148725A0 (no)
ME (1) ME00568A (no)
MX (1) MXPA02003975A (no)
MY (1) MY121175A (no)
NO (1) NO327379B1 (no)
NZ (1) NZ518299A (no)
PE (1) PE20010713A1 (no)
PL (1) PL197537B1 (no)
PT (1) PT1227817E (no)
RS (1) RS50345B (no)
SI (1) SI1227817T1 (no)
SK (1) SK286194B6 (no)
TR (1) TR200200831T2 (no)
TW (1) TWI269655B (no)
WO (1) WO2001028563A1 (no)
ZA (1) ZA200203078B (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR026073A1 (es) * 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica acuosa que contiene ciclesonida
CN100366256C (zh) 2002-07-02 2008-02-06 奥坦纳医药公司 含有环索奈德的无菌水性混悬剂
EP2295062B1 (en) 2002-08-30 2012-08-29 Nycomed GmbH The use of the combination of ciclesonide and antihistamines for the treatment of allergic rhinitis
DE60323138D1 (de) 2002-12-12 2008-10-02 Nycomed Gmbh Kombinationsarzneimittel aus r,r-formoterol und ciclesonide
MY143936A (en) 2003-03-27 2011-07-29 Nycomed Gmbh Process for preparing crystalline ciclesonide with defined particle size
ES2452691T5 (es) 2003-09-16 2022-09-14 Covis Pharma Gmbh Uso de ciclesonida para el tratamiento de enfermedades respiratorias
PE20050941A1 (es) * 2003-12-16 2005-11-08 Nycomed Gmbh Suspensiones acuosas de ciclesonida para nebulizacion
WO2006055954A2 (en) * 2004-11-17 2006-05-26 Government Of The U.S.A., As Represented By The Secretary, Department Of Health & Human Services Steroid formulation and methods of treatment using same
JP5661985B2 (ja) * 2006-12-27 2015-01-28 帝人ファーマ株式会社 無菌性水性懸濁製剤
MX2010009974A (es) 2008-03-11 2010-09-30 Alcon Res Ltd Suspensiones de acetonida de triamcinolona de baja viscosidad, altamente floculadas para inyeccion intravitrea.

Family Cites Families (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4271143A (en) 1978-01-25 1981-06-02 Alcon Laboratories, Inc. Sustained release ophthalmic drug dosage
CH657779A5 (de) 1982-10-05 1986-09-30 Sandoz Ag Galenische zusammensetzungen enthaltend calcitonin.
AU572815B2 (en) 1982-12-29 1988-05-19 Armour Pharmaceutical Company Pharmaceutical calcitonin compositions for intranasal application
JPS59163313A (ja) 1983-03-09 1984-09-14 Teijin Ltd 経鼻投与用ペプチドホルモン類組成物
US4615697A (en) 1983-11-14 1986-10-07 Bio-Mimetics, Inc. Bioadhesive compositions and methods of treatment therewith
GB8515132D0 (en) 1985-06-14 1985-07-17 British Nuclear Fuels Plc Measuring photosynthetic activities of plants
US5179079A (en) 1986-12-16 1993-01-12 Novo Nordisk A/S Nasal formulation and intranasal administration therewith
MY102411A (en) 1986-12-23 1992-06-17 Ciba Geigy Ag Nasal solutions
JPH0744940B2 (ja) 1986-12-24 1995-05-17 ライオン株式会社 口腔貼付用基材
US4802967A (en) 1987-04-08 1989-02-07 Andus Corporation Surface treatment of polymers
JPS63303931A (ja) 1987-06-05 1988-12-12 Sumitomo Pharmaceut Co Ltd 経鼻投与用成長ホルモン放出活性物質製剤
US4788220A (en) 1987-07-08 1988-11-29 American Home Products Corporation (Del.) Pediatric ibuprofen compositions
US5192535A (en) 1988-02-08 1993-03-09 Insite Vision Incorporated Ophthalmic suspensions
US5188826A (en) 1988-02-08 1993-02-23 Insite Vision Incorporated Topical ophthalmic suspensions
US5776493A (en) 1989-07-14 1998-07-07 Alza Corporation Oral osmotic device for delivery of nystatin with hydrogel driving member
ATE113841T1 (de) 1989-10-31 1994-11-15 Columbia Lab Inc Mittel zur feuchthaltung vaginalen gewebes.
US5147654A (en) 1990-07-23 1992-09-15 Alza Corporation Oral osmotic device for delivering nicotine
JPH078806B2 (ja) 1990-08-16 1995-02-01 旭化成工業株式会社 カルシトニン類含有経鼻投与用乳剤
GB9102579D0 (en) 1991-01-24 1991-03-27 Glaxo Group Ltd Compositions
GB9103824D0 (en) 1991-02-23 1991-04-10 Fisons Ag Formulation
DK0578780T3 (da) 1991-04-03 2003-08-18 Univ Vanderbilt Sænkning af thromboxanniveauer ved perkutan indgivelse af aspirin
IT1250691B (it) * 1991-07-22 1995-04-21 Giancarlo Santus Composizioni terapeutiche per somministrazione intranasale comprendenti ketorolac.
US5200195A (en) 1991-12-06 1993-04-06 Alza Corporation Process for improving dosage form delivery kinetics
JP2860729B2 (ja) 1992-03-10 1999-02-24 エスエス製薬株式会社 プラノプロフェン懸濁シロップ剤
CA2101126A1 (en) 1992-08-03 1994-02-04 Yasushi Morita Preparation for local treatment
JP3047948B2 (ja) 1992-12-07 2000-06-05 株式会社ツムラ ペプチド類経鼻投与用組成物
US5340572A (en) 1993-02-08 1994-08-23 Insite Vision Incorporated Alkaline ophthalmic suspensions
US5409703A (en) 1993-06-24 1995-04-25 Carrington Laboratories, Inc. Dried hydrogel from hydrophilic-hygroscopic polymer
JP2787131B2 (ja) 1993-07-30 1998-08-13 千寿製薬株式会社 水性懸濁液剤
US5540930A (en) 1993-10-25 1996-07-30 Pharmos Corporation Suspension of loteprednol etabonate for ear, eye, or nose treatment
JP3781792B2 (ja) 1993-12-27 2006-05-31 千寿製薬株式会社 ジフルプレドナート含有点眼用懸濁液剤
JPH07188059A (ja) 1993-12-28 1995-07-25 Rohto Pharmaceut Co Ltd 歯周病治療剤
RU2102979C1 (ru) 1994-07-18 1998-01-27 Панкрушева Татьяна Александровна Средство для лечения гнойно-воспалительных процессов кожи и слизистых оболочек различной этиологии
US5726181A (en) 1995-06-05 1998-03-10 Bionumerik Pharmaceuticals, Inc. Formulations and compositions of poorly water soluble camptothecin derivatives
AU6392496A (en) 1995-06-29 1997-01-30 Mcneil-Ppc, Inc. The combination of topical nasal antihistamines and topical nasal steroids
JP3098401B2 (ja) 1995-07-12 2000-10-16 株式会社エルティーティー研究所 経鼻投与用製剤
JP2791317B2 (ja) 1995-12-26 1998-08-27 株式会社三和化学研究所 多層フィルム製剤
KR100568436B1 (ko) 1996-02-27 2007-04-25 데이진 가부시키가이샤 분말상경비투여조성물
US5976573A (en) 1996-07-03 1999-11-02 Rorer Pharmaceutical Products Inc. Aqueous-based pharmaceutical composition
US5955097A (en) 1996-10-18 1999-09-21 Virotex Corporation Pharmaceutical preparation applicable to mucosal surfaces and body tissues
IT1286496B1 (it) 1996-11-20 1998-07-15 Leetrim Ltd Dublin Composizione farmaceutica orale ad attivita' antipiretica,analgesica ed antiinfiammatoria
FR2756739B1 (fr) 1996-12-05 2000-04-28 Astra Ab Nouvelle formulation de budesonide
SE9604486D0 (sv) 1996-12-05 1996-12-05 Astra Ab Novel formulation
TW503113B (en) 1997-01-16 2002-09-21 Senju Pharma Co Aqueous suspension for nasal administration
US6120752A (en) 1997-05-21 2000-09-19 3M Innovative Properties Company Medicinal aerosol products containing formulations of ciclesonide and related steroids
JPH1121229A (ja) 1997-06-30 1999-01-26 Kyoto Yakuhin Kogyo Kk 抗真菌性外用製剤およびその製造方法
JP3386349B2 (ja) 1997-10-30 2003-03-17 帝人株式会社 水性懸濁医薬品組成物
JP3386348B2 (ja) 1997-10-30 2003-03-17 帝人株式会社 鼻腔内投与用水性懸濁製剤
JPH11130658A (ja) 1997-10-30 1999-05-18 Teijin Ltd 水性懸濁医薬品組成物
SE9704186D0 (sv) * 1997-11-14 1997-11-14 Astra Ab New composition of matter
WO1999037286A1 (fr) * 1998-01-22 1999-07-29 Santen Pharmaceutical Co., Ltd. Collyre a suspension de fluorometholone
SE514128C2 (sv) 1998-03-17 2001-01-08 Pharmalink Ab Användning av en glukokortikoid för framställning av ett läkemedel för behandling av glomerulonefrit
TWI243687B (en) 1998-04-21 2005-11-21 Teijin Ltd Pharmaceutical composition for application to mucosa
US6124268A (en) * 1999-02-17 2000-09-26 Natreon Inc. Natural antioxidant compositions, method for obtaining same and cosmetic, pharmaceutical and nutritional formulations thereof
RU11829U1 (ru) 1999-05-05 1999-11-16 Специальное конструкторское бюро транспортного машиностроения (ОАО Спецмаш) Рабочая площадка для буровых установок
AR026072A1 (es) 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica que contiene ciclesonida para aplicacion a la mucosa
WO2001028517A1 (fr) 1999-10-20 2001-04-26 Teijin Limited Compositions therapeutiques aqueuses
AR026073A1 (es) * 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica acuosa que contiene ciclesonida

Also Published As

Publication number Publication date
NZ518299A (en) 2004-03-26
DE60011924D1 (de) 2004-08-05
KR20020060205A (ko) 2002-07-16
SI1227817T1 (en) 2004-12-31
DE60011924T2 (de) 2005-07-07
CN1198623C (zh) 2005-04-27
HU228894B1 (hu) 2013-06-28
ME00568B (me) 2011-12-20
BR0014880A (pt) 2002-06-11
AU776587B2 (en) 2004-09-16
EP1227817B1 (en) 2004-06-30
EA005201B1 (ru) 2004-12-30
IL148725A0 (en) 2002-09-12
NO20021866L (no) 2002-04-19
CN1379673A (zh) 2002-11-13
ATE270107T1 (de) 2004-07-15
PL197537B1 (pl) 2008-04-30
PE20010713A1 (es) 2001-07-13
ME00568A (en) 2011-12-20
EA200200383A1 (ru) 2002-10-31
CA2388325A1 (en) 2001-04-26
BG65799B1 (bg) 2009-12-31
PL356190A1 (en) 2004-06-14
US8383611B1 (en) 2013-02-26
JP2003512330A (ja) 2003-04-02
TWI269655B (en) 2007-01-01
HUP0203756A3 (en) 2004-06-28
PT1227817E (pt) 2004-11-30
BRPI0014880B1 (pt) 2015-08-11
MXPA02003975A (es) 2003-09-25
BG106517A (en) 2002-12-29
RS50345B (sr) 2009-11-10
CO5251406A1 (es) 2003-02-28
WO2001028563A1 (en) 2001-04-26
JP4856338B2 (ja) 2012-01-18
ES2223595T3 (es) 2005-03-01
NO327379B1 (no) 2009-06-22
AR026073A1 (es) 2002-12-26
YU28102A (sh) 2004-12-31
DK1227817T3 (da) 2004-11-15
ZA200203078B (en) 2003-01-29
SK286194B6 (sk) 2008-05-06
TR200200831T2 (tr) 2002-07-22
HRP20020345B1 (en) 2006-12-31
MY121175A (en) 2005-12-30
CA2388325C (en) 2007-09-18
HUP0203756A2 (en) 2003-05-28
HK1051003A1 (en) 2003-07-18
SK6932002A3 (en) 2002-09-10
EP1227817A1 (en) 2002-08-07
IL148725A (en) 2006-12-31
US20130095146A1 (en) 2013-04-18
HRP20020345A2 (en) 2005-10-31
KR100705372B1 (ko) 2007-04-11
BRPI0014880B8 (pt) 2021-05-25
AU7953200A (en) 2001-04-30
CZ20021284A3 (cs) 2002-07-17
CZ297780B6 (cs) 2007-03-28

Similar Documents

Publication Publication Date Title
NO20015175D0 (no) Farmasöytisk sammensetning
ITMI20001450A0 (it) Nuova composizione farmaceutica
PT1242087E (pt) Composicoes farmaceuticas
DK1466615T3 (da) Farmaceutisk præparat
BR0013417B1 (pt) composiÇço aquosa.
EE200200150A (et) Preparaat
NO20015670L (no) Forbedrede farmasöytiske formuleringer
ATE270270T1 (de) Neuartige phenylalkyloxy-phenyl-derivate
NO20015149D0 (no) Nytt farmasöytisk preparat
PT1210085E (pt) Solucoes farmaceuticas de levosimendano
NO20022606D0 (no) Farmasöytiske kombinasjoner
NO20031246D0 (no) Farmasöytisk blanding
PT1154988E (pt) Derivados de mevinolina
PT1239832E (pt) Composicoes farmaceuticas
NO20014926D0 (no) Farmasöytiske forbindelser
NO20015148D0 (no) Nytt farmasöytisk preparat
NO20021866L (no) Ciclesonid-inneholdende vandig farmasoytisk blanding
ID30032A (id) Formulasi farmasi
FI4488U1 (fi) Farmaseuttinen koostumus
NO20015104L (no) Nytt farmasöytisk preparat
PT1088818E (pt) Derivados de quinolin-4-ilo
AR025867A1 (es) Formulacion portasdora farmaceutica
NO20016430L (no) Farmasöytisk kompleks
NO20015105L (no) Nytt farmasöytisk preparat
NO20021036L (no) Farmasöytisk preparat

Legal Events

Date Code Title Description
CREP Change of representative

Representative=s name: PLOUGMANN & VINGTOFT, POSTBOKS 1003 SENTRUM, 0104

CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: TAKEDA GMBH, DE

CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: TAKEDA GMBH, DE

CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: ASTRAZENECA AB, SE

CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: COVIS PHARMA B.V., CH

CREP Change of representative

Representative=s name: BRYN AARFLOT AS, STORTINGSGATA 8, 0161 OSLO, NORGE

MK1K Patent expired